Measles
📧 Sign up to get email alerts when something new happens for Measles.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants [Phase 2, Phase 3]
This clinical trial update reports on the immunogenicity and reactogenicity of the trivalent measles-mumps-rubella vaccine Trivivac in healt…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: A Study of ProQuad™ in Healthy Children in Korea (V221-023) [Phase 3]
Phase 3 trial of ProQuad in healthy children in Korea was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years [Phase 2]
Phase 2 trial evaluating safety, dose response, and immunogenicity of the Measles Vaccine MVA mBN85B in healthy children aged 6 months to 6 …
-
CLINICAL_TRIALS research · 2012-05-18Clinical Trial Update: Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
A clinical trial update examining immunity to the measles virus in Thai adults aged 18-30 and investigating predictive factors for immune re…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Early Two-dose Measles Vaccination Trial [Phase 4]
The clinical trial update reports the completion of a Phase 4 study evaluating an early two-dose measles vaccination schedule.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age [Phase 2]
Phase 2 trial evaluating the immunogenicity of GSK's MMR vaccine (209762) compared with M-M-R II when co-administered with routine vaccines …
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Immunology of Non-specific Effects of Vaccine [Phase 4]
Phase 4 clinical trial evaluating non-specific immunological effects of vaccines has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Long-term Follow-up of Measles Antibodies [Phase 4]
Phase 4 trial reporting long-term follow-up data on measles antibodies, describing persistence over time.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers [Phase 3]
A Phase 3 safety study evaluating the co-administration of Menactra meningococcal vaccine with other pediatric vaccines in healthy toddlers;…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers [Phase 3]
This Phase 3 trial evaluated the immunogenicity and safety of pediatric vaccines administered with Menactra in healthy toddlers, with result…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 3]
A Phase 3 study evaluated two doses of Menactra meningococcal conjugate vaccine in healthy toddlers. The trial is completed and results were…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Immune Responses to Two Dose Varivax +/- MMR-II [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing immune responses to two doses of Varivax with or without MMR-II in measles, mumps, rubella, and varicel…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
The trial update describes immune responses of premature infants to the Measles-Mumps-Rubella (MMR) and Varicella vaccines, with the study s…
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age [Phase 2]
Phase 2 trial comparing MMRV vaccine from GlaxoSmithKline to ProQuad in children 12-14 months, assessing immunogenicity and safety for varic…
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines [Phase 3]
A Phase 3 study evaluated administering Frozen ProQuad concurrently with other pediatric vaccines versus separately, with results posted Feb…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: ProQuad Dose Selection Study (V221-011)(COMPLETED) [Phase 2]
A Phase 2 dose-selection study of ProQuad evaluated different dosing regimens to determine the optimal dose for protection against measles, …
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) [Phase 3]
Phase 3 trial comparing ProQuad (MMRV) with separate M-M-R II (MMR) and VARIVAX (varicella) vaccines in healthy children; the study is compl…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) [Phase 3]
Phase 3 clinical trial update reporting results for V221-019, a concomitant-use study with Pneumococcal Conjugate Vaccine sponsored by Merck…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) [Phase 3]
This Phase 3 clinical trial evaluated safety, tolerability, and immunogenicity across three frozen ProQuad lot consistency lots in healthy c…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) [Phase 3]
Phase 3 trial of ProQuad in healthy children completed; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…
-
CLINICAL_TRIALS trial_result · 2009-01-23Clinical Trial Update: Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the measles vaccine in patients with measles virus-positive, advanced non-small cell lung cancer; t…
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) [Phase 4]
A Phase 4 safety study evaluating Merck's Hepatitis A inactivated vaccine and Measles, Mumps, Rubella and Varicella Live vaccine (ProQuad) h…
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) using two administration routes; …
-
CLINICAL_TRIALS research · 2008-03-28Clinical Trial Update: The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants [NA]
Clinical trial exploring whether probiotics modulate infants' immunologic response to vaccines, with a focus on measles, mumps, and rubella;…